Jeremy Quirk

Jeremy Quirk has extensive experience in the pharmaceutical and biotechnology sectors, currently serving as Vice President of Business Development & Licensing Commercial Portfolio and Vice President of Pipeline & Portfolio Strategy Group at GSK since November 2018. Prior to GSK, Jeremy held the position of Vice President of Global Analytics & Intelligence at AstraZeneca from April 2014 to October 2017, and served as Senior Disease Area Director at Roche from January 2006 to March 2014. Academically, Jeremy holds a Doctor of Philosophy in Molecular Genetics, Oncology & Developmental Biology from UCL, alongside multiple master's degrees in areas such as Strategy & Leadership from London Business School, Behavioural Economics & Behavioural Science, Health Economics & Policy Management from The London School of Economics and Political Science (LSE), an MBA from the University of Edinburgh Business School, and a master's degree in Research Methodology and Quantitative Methods from IE Business School. Additionally, Jeremy earned a Bachelor of Science in Biochemistry and Molecular Biology from The University of Manchester.